Sai Parenteral's Limited (NSE:SAIPARENT)

India · Delayed Price · Currency is INR

486.70

+6.60 (1.37%)

At close: May 22, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
CDMO Products and Services	312.46M	187.37M	53.17M
CDMO Products and Services Growth	66.76%	252.40%	-
Branded Generic Formulations	1.27B	1.31B	914.79M
Branded Generic Formulations Growth	-2.93%	43.31%	-
Total	1.59B	1.50B	967.96M
Total Growth	5.79%	54.79%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
India	1.33B	1.41B	942.40M
India Growth	-5.79%	49.44%	-
Australia	162.70M	68.27M	16.92M
Australia Growth	138.32%	303.49%	-
South Africa	5.32M	6.31M	4.85M
South Africa Growth	-15.69%	30.10%	-
Philippines	10.59M	-	-
UAE (Dubai)	5.88M	12.28M	-
UAE (Dubai) Growth	-52.12%	-	-
Uganda	3.33M	-	-
Nigeria	7.60M	-	-
Iraq	44.55M	-	-
Tanzania	12.48M	-	-
Others	5.78M	3.14M	3.79M
Others Growth	84.08%	-17.15%	-
Total	1.59B	1.50B	967.96M
Total Growth	5.79%	54.79%	-

Source: S&P Global Market Intelligence.